Hereditary Cancer Syndrome
11
6
8
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
Cell-free DNA in Hereditary And High-Risk Malignancies 1
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
CfDNA in Hereditary And High-risk Malignancies 2
Integrative Sequencing In Germline and Hereditary Tumours
Cancer Health Assessments Reaching Many
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
Evaluation of the Adhesion to the GENEPY Network